Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 28 September 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

MR colonography for the detection of cclorectal neoplasia in asymptomatic adults

This month's issue of Gastroenterology investigates magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.

News image

Colonoscopy is the preferred screening test for colorectal neoplasia.

The fecal occult blood test detects neoplasias with low levels of sensitivity.

Computed tomographic colonography detects neoplasias with high levels of sensitivity but involves exposure to radiation.

Dr Anno Graser from Germany reported that they investigated whether magnetic resonance colonography can be used to screen for colorectal adenomas and cancers.

The team analyzed data from 286 asymptomatic adults who underwent 3 Tesla magnetic resonance colonography and colonoscopic examinations on the same day.

The research team reported that the fecal occult blood test was performed before bowel preparation.

Colonoscopists were initially blinded to the findings on magnetic resonance colonography and unblinded after withdrawal from the respective segments.

The team of doctors calculated sensitivities for adenoma and per-patient sensitivities, and specificities based on the unblinded results of colonoscopy.

Sensitivities of MR colonography, and colonoscopy for adenomas 6 mm were 78%
Gastroenterology

The researchers detected 133 adenomas and 2 cancers in 86 patients.

The team found that 37 adenomas were 6 mm, and 20 adenomas were advanced.

The researchers reported that sensitivities of magnetic resonance colonography, and colonoscopy for adenomas 6 mm were 78% and 97%.

For advanced adenomas these values were 75% and 100%, respectively.

Magnetic resonance colonography identified 87%, colonoscopy identified 97%, and fecal occult blood test 10% of individuals with adenomas 6 mm and 84%, 100%, and 18% of individuals with advanced neoplasia.

The doctors found that specificities of magnetic resonance colonography , colonoscopy, and fecal occult blood test for individuals with adenomas 6 mm were 95%, 97% , and 92%, respectively.

Dr Graser's team commented, "3 Tesla magnetic resonance colonography detects colorectal adenomas 6 mm, and advanced neoplasia with high levels of sensitivity and specificity."

"Although magnetic resonance colonography  detects colorectal neoplasia with lower levels of sensitivity than colonoscopy, it strongly outperforms one-time fecal occult blood test."

Gastroenterol 2013: 144(4): 743-750
01 April 2013

Go to top of page Email this page Email this page to a colleague

 28 September 2016 
Heterogeneity in endoscopic treatment of Crohn’s
 28 September 2016 
Global trends in pancreatic cancer mortality
 28 September 2016 
Hep C virus RNA in liver explants
 27 September 2016 
Non-invasive tests of NAFLD
 27 September 2016 
Fecal microbiota transplantation for C.diff in IBD
 27 September 2016 
Fast-track colorectal surgery influences outcomes
 26 September 2016 
Preventing cirrhosis in Hep C with fibrosis
 26 September 2016 
Body image after abdominoperineal excision for rectal cancer
 26 September 2016 
Gastric cancer risk in intestinal metaplasia of the stomach
 23 September 2016 
Sleep quality in nonalcoholic cirrhotic patients
 23 September 2016 
Exercise for NAFLD
 23 September 2016 
BMI history and fatty liver
 22 September 2016 
Predicting small-bowel Crohn’s disease
 22 September 2016 
Colectomy outcomes for ulcerative colitis
 22 September 2016 
Technology vs intervention for weight loss
 21 September 2016 
Employment status and IBD
 21 September 2016 
Cardiopulmonary exercise testing in liver transplant candidates
 21 September 2016 
Patients vs providers on nutrition in IBD
 20 September 2016 
Improving healthcare systems for viral Hepatitis
 20 September 2016 
GI benefits of COX-2 selective inhibitors
 20 September 2016 
Predicting relapse in Crohn's
 19 September 2016 
Prevalence of esophageal cancer in Barrett's
 19 September 2016 
Fecal microbiota transplantation and CDI in IBD
 19 September 2016 
Antibiotic resistance in Helicobacter pylori
 16 September 2016 
Low-residue diet before colonoscopy and bowel cleansing
 16 September 2016 
Genome-wide association in gastric cancer
 16 September 2016 
H. pylori in children with asthma
 15 September 2016 
Improving survival in cholangitis-associated septic shock
 15 September 2016 
Primary sclerosing cholangitis and IBD
 15 September 2016 
Colorectal cancer survival and hospital volumes
 14 September 2016 
Intestinal malabsorption and olmesartan
 14 September 2016 
Infection reduction strategy after colorectal resection
 14 September 2016 
Predicting long-term infliximab use in Crohn's
 13 September 2016 
Predicting survival in refractory celiac disease
 13 September 2016 
Cancer risk stratification in Barrett’s
 13 September 2016 
Screening vs non-screening colonoscopy
 12 September 2016 
Screening in familial colorectal cancer
 12 September 2016 
Metformin improves survival in pancreatic ductal cancer
 12 September 2016 
Consent guidelines for GI endoscopy procedures
 09 September 2016 
Development of IBS
 09 September 2016 
Safe and effective treatment for NASH
 09 September 2016 
Scale for stool measurement in diarrhea-IBS
 08 September 2016 
Prognostic factors for infliximab in Crohn's
 08 September 2016 
Chronic Hep B vs chronic Hep C and mortality
 08 September 2016 
Hematological malignancies in IBD
 07 September 2016 
IBD relapse during pregnancy
 07 September 2016 
New treatments for ulcerative colitis
 07 September 2016 
Alternative to nucleic acid testing in HCV
 06 September 2016 
Endoscopy clinic no-shows
 06 September 2016 
Risk of infection after elective colorectal surgery
 06 September 2016 
EHealth technologies in IBD
 05 September 2016 
Esophageal impedance monitoring
 05 September 2016 
Family history and IBD clinical course
 05 September 2016 
Biomarker for IBD and GI cancer
 02 September 2016 
Dietary carbohydrate intake, insulin resistance and GERD 
 02 September 2016 
Postpolypectomy bleeding in the colorectum
 02 September 2016 
Postop recurrence of Crohn's
 01 September 2016 
Prognostic test for liver transplants
 01 September 2016 
Recovery after colorectal surgery in elderly patients
 01 September 2016 
Obesity and post-ERCP pancreatitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us